Yawar J Qadri1, Andrey V Bortsov1, Danielle C Orrey1, Robert A Swor2, David A Peak3, Jeffrey S Jones4, Niels K Rathlev5, David C Lee6, Robert M Domeier7, Phyllis L Hendry8, Samuel A Mclean1,8. 1. Department of Anesthesiology, University of North Carolina, Chapel Hill, NC. 2. Department of Emergency Medicine, William Beaumont Hospital, Royal Oak. 3. Department of Emergency Medicine, Massachusetts General Hospital, Boston. 4. Department of Emergency Medicine, Spectrum Health System, Grand Rapids. 5. Department of Emergency Medicine, Bay State Medical Center, Springfield, MA. 6. Department of Emergency Medicine, North Shore University Hospital, Manhasset, NY. 7. Department of Emergency Medicine, Saint Joseph Mercy Health System, Ypsilanti, MI. 8. Department of Emergency Medicine, University of Florida, Jacksonville, FL.
Abstract
OBJECTIVES: Dopaminergic signaling is implicated in nociceptive pathways. These effects are mediated largely through dopamine receptors and modulated in part by dopamine transporters. This study tested the hypothesis that genetic variants in the genes encoding dopamine receptor 2 (DRD2) and the dopamine active transporter (SLC6A3) influence acute pain severity after motor vehicle collision. MATERIALS AND METHODS: European Americans presenting to the emergency department after motor vehicle collision were recruited. Overall pain intensity in emergency department was assessed using a 0 to 10 numeric rating scale. DNA was extracted from blood samples and genotyping of single-nucleotide polymorphisms (SNPs) in the DRD2 and SLC6A3 gene was performed. RESULTS: A total of 948 patients completed evaluation. After correction for multiple comparisons, SNP rs6276 at DRD2 showed significant association with pain scores, with individuals with the A/A genotype reporting lower mean pain scores (5.3; 95% confidence interval [CI], 5.1-5.5) than those with A/G (5.9; 95% CI, 5.6-6.1) or G/G (5.7; 95% CI, 5.2-6.2) genotypes (P=0.0027). Secondary analyses revealed an interaction between sex and DRD2 SNPs rs4586205 and rs4648318 on pain scores: females with 2 minor alleles had increased pain intensity, whereas males with 2 minor alleles had less pain than individuals with a major allele (interaction P=0.0019). DISCUSSION: Genetic variants in DRD2 are associated with acute pain after a traumatic stressful event. These results suggest that dopaminergic agents may be useful for the treatment of individuals with acute posttraumatic pain as part of a multimodal opioid-sparing analgesic regimen.
OBJECTIVES: Dopaminergic signaling is implicated in nociceptive pathways. These effects are mediated largely through dopamine receptors and modulated in part by dopamine transporters. This study tested the hypothesis that genetic variants in the genes encoding dopamine receptor 2 (DRD2) and the dopamine active transporter (SLC6A3) influence acute pain severity after motor vehicle collision. MATERIALS AND METHODS: European Americans presenting to the emergency department after motor vehicle collision were recruited. Overall pain intensity in emergency department was assessed using a 0 to 10 numeric rating scale. DNA was extracted from blood samples and genotyping of single-nucleotide polymorphisms (SNPs) in the DRD2 and SLC6A3 gene was performed. RESULTS: A total of 948 patients completed evaluation. After correction for multiple comparisons, SNP rs6276 at DRD2 showed significant association with pain scores, with individuals with the A/A genotype reporting lower mean pain scores (5.3; 95% confidence interval [CI], 5.1-5.5) than those with A/G (5.9; 95% CI, 5.6-6.1) or G/G (5.7; 95% CI, 5.2-6.2) genotypes (P=0.0027). Secondary analyses revealed an interaction between sex and DRD2 SNPs rs4586205 and rs4648318 on pain scores: females with 2 minor alleles had increased pain intensity, whereas males with 2 minor alleles had less pain than individuals with a major allele (interaction P=0.0019). DISCUSSION: Genetic variants in DRD2 are associated with acute pain after a traumatic stressful event. These results suggest that dopaminergic agents may be useful for the treatment of individuals with acute posttraumatic pain as part of a multimodal opioid-sparing analgesic regimen.
Authors: John Houston; Sweta Dharia; Jeffrey R Bishop; Vicki L Ellingrod; Bonnie Fijal; Jennie G Jacobson; Vicki P Hoffmann Journal: Psychiatry Res Date: 2010-11-20 Impact factor: 3.222
Authors: U Finckh; H Rommelspacher; S Kuhn; P Dufeu; G Otto; A Heinz; M Dettling; M Giraldo-Velasquez; J Pelz; K J Gräf; H Harms; T Sander; L G Schmidt; A Rolfs Journal: Pharmacogenetics Date: 1997-08
Authors: E G Jönsson; M M Nöthen; F Grünhage; L Farde; Y Nakashima; P Propping; G C Sedvall Journal: Mol Psychiatry Date: 1999-05 Impact factor: 15.992
Authors: Luda Diatchenko; Andrea G Nackley; Gary D Slade; Kanokporn Bhalang; Inna Belfer; Mitchell B Max; David Goldman; William Maixner Journal: Pain Date: 2006-07-11 Impact factor: 6.961
Authors: Weihua Huang; Thomas J Payne; Jennie Z Ma; Joke Beuten; Randolph T Dupont; Naohiro Inohara; Ming D Li Journal: Neuropsychopharmacology Date: 2008-03-19 Impact factor: 7.853
Authors: G A Wiesbeck; T Mueller; N Wodarz; E Davids; T Kraus; J Thome; H G Weijers; J Boening Journal: Drug Alcohol Depend Date: 1998-09-01 Impact factor: 4.492
Authors: Barbara C van Munster; Sophia E J A de Rooij; Mojgan Yazdanpanah; Pentti J Tienari; Kaisu H Pitkälä; Robert J Osse; Dimitrios Adamis; Orla Smit; Marijke S van der Steen; Miriam van Houten; Terhi Rahkonen; Raimo Sulkava; Jouko V Laurila; Timo E Strandberg; Joke H M Tulen; Louwerens Zwang; Alastair J D MacDonald; Adrian Treloar; Eric J G Sijbrands; Aeilko H Zwinderman; Johanna C Korevaar Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2010-03-05 Impact factor: 3.568
Authors: Carlo Asuni; Allesandra Cherchi; Donatella Congiu; Maria P Piccardi; Maria Del Zompo; Maria E Stochino Journal: J Headache Pain Date: 2007-06-11 Impact factor: 7.277
Authors: Patrick Linsel-Nitschke; Anika Götz; Jeanette Erdmann; Ingrid Braenne; Peter Braund; Christian Hengstenberg; Klaus Stark; Marcus Fischer; Stefan Schreiber; Nour Eddine El Mokhtari; Arne Schaefer; Jürgen Schrezenmeir; Jürgen Schrezenmeier; Diana Rubin; Anke Hinney; Thomas Reinehr; Christian Roth; Jan Ortlepp; Peter Hanrath; Alistair S Hall; Massimo Mangino; Wolfgang Lieb; Claudia Lamina; Iris M Heid; Angela Doering; Christian Gieger; Annette Peters; Thomas Meitinger; H-Erich Wichmann; Inke R König; Andreas Ziegler; Florian Kronenberg; Nilesh J Samani; Heribert Schunkert Journal: PLoS One Date: 2008-08-20 Impact factor: 3.240
Authors: Cornelius B Groenewald; Emily F Law; Emma Fisher; Sarah E Beals-Erickson; Tonya M Palermo Journal: J Pain Date: 2018-08-09 Impact factor: 5.820
Authors: Sarah D Linnstaedt; JunMei Hu; Andrea Y Liu; April C Soward; Kenneth A Bollen; Henry E Wang; Phyllis L Hendry; Erin Zimny; Christopher Lewandowski; Marc-Anthony Velilla; Kathia Damiron; Claire Pearson; Robert Domeier; Sangeeta Kaushik; James Feldman; Mark Rosenberg; Jeffrey Jones; Robert Swor; Niels Rathlev; Samuel A McLean Journal: BMJ Open Date: 2016-09-06 Impact factor: 2.692
Authors: Anna Michalczyk; Justyna Pełka-Wysiecka; Jolanta Kucharska-Mazur; Michał Wroński; Błażej Misiak; Jerzy Samochowiec Journal: Ann Gen Psychiatry Date: 2020-06-17 Impact factor: 3.455